1. Introduction {#s0005}
===============

Perimenopausal period, also known as menopause, is the transition from the reproductive age of women to the elderly (about 45--55 years old), due to a series of changes in ovarian dysfunction. Clinical manifestations of menstrual disorders to menopause, memory loss, irritability, tidal sweat, insomnia, joint pain, etc., is a necessary stage for every woman\'s life, have seriously affected women\'s physical and mental health, work and life ([@b0060]). Chinese medicine using the overall concept and syndrome differentiation theory, according to different physical, syndromes treatment of perimenopausal syndrome, efficacy and less adverse reactions. What we need to be concerned about is that women\'s perioperative prevention is particularly important, in the treatment of perimenopausal syndrome at the same time, should fully reflect the traditional Chinese medicine "treatment did not occur disease" thinking, take preventive measures. To avoid low-level Chinese medicine treatment of perimenopausal syndrome experimental and clinical research, under the guidance of traditional Chinese medicine theory, combined with traditional Chinese medicine technology and methods to strengthen scientific research and experimental design, unified standardized dialectical system, to find the objective of the disease differentiation indicators, the establishment of standardized index system, improve the scientific, objectivity and reliability of Chinese medicine for perimenopausal syndrome ([@b0030], [@b0045]). Raspberry as a traditional nourishing kidney medicine, in China has thousands of years of use history, researchers from the raspberry separation of terpenoids, flavonoids, alkaloids, coumarins and other ingredients, and the preliminary pharmacological screening was carried out for the isolated compounds, in the anti-tumor, anti-aging, scavenging free radicals and other aspects of a clear activity. Perimenopausal care is a hot issue that is of great concern both at home and abroad, China's perimenopausal women ranks first in the world, therefore, the search for perimenopausal drugs and research is more urgent. In this study, ovarian castration was used to induce the perimenopausal model of mice to observe the effect of TFR on perimenopausal effects in mice ([@b0020]).

2. Materials and methods {#s0010}
========================

2.1. Animals {#s0015}
------------

KM mice, female, 20--25 g, provided by the Wuhan Institute of Biological Products (Animal permit number: 42000400000611). Laboratory Certificate of Conformity: SYXK (Henan) 2010-001.

2.2. Experimental reagents and drugs {#s0020}
------------------------------------

Injection of penicillin sodium, North China Pharmaceutical Co., Ltd., specifications: 4 million units, lot: c1206807; Raspberry, Anhui Xinxing Chinese Herbal Medicine Pieces Co., Ltd., lot: 20130901; raspberry total flavonoids, ethanol extracted AB-8 microporous resin, the content of 57.86%; Gengnianan capsule, Shanxi Star Pharmaceutical Co., Ltd. production, lot: 121104; Soybean isoflavones E soft capsule, Weihai Purple Biotechnology Development Co., Ltd. production, lot: 13070302.

2.3. Experimental instruments {#s0025}
-----------------------------

Autonomic activities test instrument, Chengdu taimeng Technology Co. Ltd., model: ZZ-6; mouse step through instrument, Chengdu taimeng Technology Co. Ltd., model: BA-200; high speed refrigerated centrifuge, science innovation Limited by Share Ltd Zhongjia branch, model: KDC-160HR; eliasa, BIO-RAD, model: 680.

2.4. Modeling and administration {#s0030}
--------------------------------

100 mice weighing 23--25 g female KM mice were randomly selected 12 as the blank group, the sham operation was treated, and all the other mice were made of menopausal model. Mice were intraperitoneally injected with 10% chloral hydrate (0.03 ml/10 g) anesthesia after abdominal fixation, first cut the ovarian fallopian tube (including fat) with a thin line ligation, and then remove the bilateral ovaries. After intensive care, intramuscular injection of penicillin 200,000 u/kg (0.1 mL each) to prevent infection, continuous 3 days, once a day. 5 days after the start of the mouse vaginal smear, once a day for 5 days to determine whether the complete removal of ovaries ([@b0070]). The smear showed the Estrus reaction of the mouse to abandon. Choose 72 mice castrated completely random divided into 6 groups for the experiment, respectively: model group, GNA capsule group, SIS capsule group, high, mid and low dose group of TFR. Animals in each group were given corresponding drugs tenth days after operation, GNA capsule group fed GNA capsule suspension 675 mg/kg, SIS capsule group fed SIS capsule suspension 250 mg/kg, high, mid and low dose group of TFR respectively by gavage, high, mid and low dose of TFR 200 mg/kg, 100 mg/kg, 50 mg/kg, blank group and model group were fed with the same volume of 0.5% CMC solution. 1 times a day, 0.1 ml/10 g, continuous administration of 21 days. Each group of mice in the administration of 18 days to determine the number of autonomic activities within 5 min, in the administration of 19--20 days to determine the incubation of the mice first entry into the darkroom and the number of shocks into the darkroom within 5 min. At 2 h after the last administration (fasting for 12 h), mice were sacrificed and serum was collected. Serum levels of E2, T, LH and FSH were measured. Dissect the uterus, uterus, thymus and spleen. Weigh the wet weight and calculate the organ index, the path morphology changes of uterus, thymus and spleen were observed.

2.5. Method statistical analysis {#s0035}
--------------------------------

SPSS 17.0 for windows has been used for statistical processing. The measurement data is represented by mean ± variance ($\overline{\text{x}}$ ± s), and group comparison has adopted analysis of variance; and the Rid it tests has been used to rank the data.

3. Results {#s0040}
==========

3.1. Effect of autonomic activity on the perimenopausal period in mice {#s0045}
----------------------------------------------------------------------

From the [Table 1](#t0005){ref-type="table"}, compared with the blank group, the number of autonomic activities and stands were significantly reduced in the model group, (P \< 0.01), indicating that the mice in the model group reduced the curiosity of the fresh environment. Compared with the model group, the GNA capsule group, SIS capsule group, high and mid dose group of TFR could significantly increase the number of activities and standing (P \< 0.01), low dose group of TFR could increase the number of activities and standing (P \< 0.05).Table 1Effect of autonomic activity on the perimenopausal period in mice ($\overline{\text{x}}$ ± s, n = 12).GroupDose (mg/kg)Number of activities (frequency)Number of standing (frequency)Blank group--134.333 ± 18.102[\*\*](#tblfn2){ref-type="table-fn"}59.583 ± 8.959[\*\*](#tblfn2){ref-type="table-fn"}Model group--85.667 ± 11.55527.333 ± 5.662GNA capsule group675130.500 ± 19.870[\*\*](#tblfn2){ref-type="table-fn"}52.083 ± 11.365[\*\*](#tblfn2){ref-type="table-fn"}SIS capsule group250125.917 ± 11.547[\*\*](#tblfn2){ref-type="table-fn"}50.167 ± 14.640[\*\*](#tblfn2){ref-type="table-fn"}TFR high-dose group200123.083 ± 14.902[\*\*](#tblfn2){ref-type="table-fn"}45.500 ± 10.068[\*\*](#tblfn2){ref-type="table-fn"}TFR mid-dose group100134.583 ± 17.926[\*\*](#tblfn2){ref-type="table-fn"}43.750 ± 8.159[\*\*](#tblfn2){ref-type="table-fn"}TFR low-dose group50104.750 ± 12.263[\*](#tblfn1){ref-type="table-fn"}36.667 ± 5.805[\*](#tblfn1){ref-type="table-fn"}[^1][^2][^3]

3.2. Effect of memory on the perimenopausal period in mice {#s0050}
----------------------------------------------------------

From the [Table 2](#t0010){ref-type="table"}, compared with the blank group, the latent period and the number of shocks were significantly increased in the model group (P \< 0.01). Reflecting the decline in memory of the perimenopausal model of mice ([@b0080]). Compared with the model group, the GNA capsule group, SIS capsule group, high and mid dose group of TFR could significantly improve the incubation period of mice in avoid dark experiments and reduce the number of shocks (P \< 0.01), improve mice memory. Low dose group of TFR could reduce the number of shocks (P \< 0.05).Table 2Effects of TFR on the incubation period and the number of shocks in the mice perimenopausal model ($\overline{\text{x}}$ ± s, n = 12).GroupDose (mg/kg)Icubation period (S)Number of shocks (frequency)Blank group--191.000 ± 52.401[\*\*](#tblfn4){ref-type="table-fn"}1.917 ± 1.730[\*\*](#tblfn4){ref-type="table-fn"}Model group--79.000 ± 22.0666.500 ± 1.314GNA capsule group675163.833 ± 38.879[\*\*](#tblfn4){ref-type="table-fn"}3.000 ± 1.537[\*\*](#tblfn4){ref-type="table-fn"}SIS capsule group250166.667 ± 24.403[\*\*](#tblfn4){ref-type="table-fn"}3.333 ± 0.888[\*\*](#tblfn4){ref-type="table-fn"}TFR high-dose group200160.167 ± 26.219[\*\*](#tblfn4){ref-type="table-fn"}2.000 ± 0.953[\*\*](#tblfn4){ref-type="table-fn"}TFR mid -dose group100151.833 ± 32.755[\*\*](#tblfn4){ref-type="table-fn"}2.667 ± 0.985[\*\*](#tblfn4){ref-type="table-fn"}TFR low -dose group5094.917 ± 7.8914.167 ± 1.642[\*](#tblfn3){ref-type="table-fn"}[^4][^5][^6]

3.3. Effect of organ index on the perimenopausal period in mice {#s0055}
---------------------------------------------------------------

From the [Table 3](#t0015){ref-type="table"}, compared with the blank group, the uterine index of the model group was significantly decreased (P \< 0.01), indicating that ovariectomy led to perimenopausal model mice uterine atrophy, removal of ovaries and thus estrogen deficiency lead to perimenopausal mice immune organ atrophy. Compared with the model group, the GNA capsule group, SIS capsule group, high and mid dose group of TFR could significantly improve thymus, spleen, uterine index (P \< 0.01).Table 3Effects of TFR on the thymus, spleen, uterine index in the mice perimenopausal model ($\overline{\text{x}}$ ± s, n = 12).GroupDose (mg/kg)Thymus index (mg/g)Spleen index (mg/g)Uterine index (mg/g)Blank group--3.116 ± 0.613[\*\*](#tblfn5){ref-type="table-fn"}6.115 ± 0.904[\*\*](#tblfn5){ref-type="table-fn"}3.116 ± 0.613[\*\*](#tblfn5){ref-type="table-fn"}Model group--1.685 ± 0.2763.868 ± 0.9661.699 ± 0.525GNA capsule group6752.996 ± 0.092[\*\*](#tblfn5){ref-type="table-fn"}5.851 ± 0.641[\*\*](#tblfn5){ref-type="table-fn"}2.971 ± 0.341[\*\*](#tblfn5){ref-type="table-fn"}SIS capsule group2503.067 ± 0.623[\*\*](#tblfn5){ref-type="table-fn"}5.793 ± 1.114[\*\*](#tblfn5){ref-type="table-fn"}3.073 ± 0.870[\*\*](#tblfn5){ref-type="table-fn"}TFR high-dose group2002.949 ± 0.559[\*\*](#tblfn5){ref-type="table-fn"}5.935 ± 0.959[\*\*](#tblfn5){ref-type="table-fn"}2.946 ± 0.426[\*\*](#tblfn5){ref-type="table-fn"}TFR mid -dose group1002.893 ± 0.111[\*\*](#tblfn5){ref-type="table-fn"}5.791 ± 0.932[\*\*](#tblfn5){ref-type="table-fn"}2.903 ± 0.416[\*\*](#tblfn5){ref-type="table-fn"}TFR low -dose group501.964 ± 0.5474.563 ± 1.0822.006 ± 0.644[^7][^8][^9]

3.4. Effect of serum sex hormone level on the perimenopausal period in mice {#s0060}
---------------------------------------------------------------------------

From the [Table 4](#t0020){ref-type="table"}, compared with the blank group, the levels of E2 and T were significantly decreased (P \< 0.01), and the levels of LH and FSH were significantly increased in the model group mice serum (P \< 0.01). Indicating that the removal of ovarian lead to perimenopausal model mice serum levels of sex hormones disorder, perimenopausal mouse model replication success. Compared with the model group, the GNA capsule group, SIS capsule group, high and mid dose group of TFR could significantly increase the levels of E2 and T, decreased the levels of FSH and LH in the mice serum of the perimenopausal model (P \< 0.01). Low dose group of TFR could increase the levels of T and decreased the levels of FSH (P \< 0.05).Table 4Effects of TFR on the serum sex hormone level in the mice perimenopausal model ($\overline{\text{x}}$ ± s, n = 12).GroupDose (mg/kg)E2 (pmol/L)T (pg/mL)FSH (U/mL)LH (U/mL)Blank group--30.623 ± 4.055[\*\*](#tblfn7){ref-type="table-fn"}369.548 ± 43.958[\*\*](#tblfn7){ref-type="table-fn"}11.739 ± 5.326[\*\*](#tblfn7){ref-type="table-fn"}1.013 ± 0.300[\*\*](#tblfn7){ref-type="table-fn"}Model group--20.595 ± 3.567207.167 ± 49.35823.558 ± 4.5532.184 ± 0.361GNA capsule group67528.208 ± 1.965[\*\*](#tblfn7){ref-type="table-fn"}328.833 ± 33.177[\*\*](#tblfn7){ref-type="table-fn"}13.773 ± 4.900[\*\*](#tblfn7){ref-type="table-fn"}1.272 ± 0.332[\*\*](#tblfn7){ref-type="table-fn"}SIS capsule group25028.975 ± 2.692[\*\*](#tblfn7){ref-type="table-fn"}334.310 ± 41.010[\*\*](#tblfn7){ref-type="table-fn"}14.587 ± 3.661[\*\*](#tblfn7){ref-type="table-fn"}1.177 ± 0.220[\*\*](#tblfn7){ref-type="table-fn"}TFR high-dose group20028.017 ± 2.249[\*\*](#tblfn7){ref-type="table-fn"}309.615 ± 73.141[\*](#tblfn6){ref-type="table-fn"}13.159 ± 4.847[\*\*](#tblfn7){ref-type="table-fn"}1.204 ± 0.111[\*\*](#tblfn7){ref-type="table-fn"}TFR mid-dose group10027.208 ± 1.205[\*\*](#tblfn7){ref-type="table-fn"}355.000 ± 43.311[\*\*](#tblfn7){ref-type="table-fn"}14.601 ± 4.256[\*\*](#tblfn7){ref-type="table-fn"}1.279 ± 0.117[\*\*](#tblfn7){ref-type="table-fn"}TFR low-dose group5021.097 ± 2.038273.910 ± 32.231[\*](#tblfn6){ref-type="table-fn"}17.261 ± 3.676[\*](#tblfn6){ref-type="table-fn"}1.666 ± 0.507[^10][^11][^12]

3.5. Effect of uterine path morphology on the perimenopausal period in mice {#s0065}
---------------------------------------------------------------------------

From the [Table 5](#t0025){ref-type="table"}, compared with the blank group, in model group, there were significant pathological changes in uterus (P \< 0.01), endometrial epithelial cells, glands were obvious atrophy ([Fig. 1](#f0005){ref-type="fig"}B). Compared with the model group, the GNA capsule group, SIS capsule group, mid dose group of TFR could significantly improve the pathological changes of the uterus in mice (P \< 0.01), endometrial epithelial cells, glands small part of atrophy ([Fig. 1](#f0005){ref-type="fig"}C, D, F). High dose group of TFR could improve the pathological changes of the uterus in mice (P \< 0.05), endometrial epithelial cells, glands partial atrophy ([Fig. 1](#f0005){ref-type="fig"}E).Fig. 1Effect of uterine path morphology on the perimenopausal period in mice (HE × 200).Table 5Effects of TFR on uterine path morphology in the mice perimenopausal model ($\overline{\text{x}}$ ± s, n = 12).GroupDose (mg/kg)−++++++PBlank group--11100Model group--0246△△GNA capsule group6753531[\*\*](#tblfn9){ref-type="table-fn"}SIS capsule group2503450[\*\*](#tblfn9){ref-type="table-fn"}TFR high-dose group2003431[\*](#tblfn8){ref-type="table-fn"}TFR mid -dose group1004620[\*\*](#tblfn9){ref-type="table-fn"}TFR low -dose group500363[^13][^14][^15][^16]

3.6. Effect of thymus, spleen path morphology on the perimenopausal period in mice {#s0070}
----------------------------------------------------------------------------------

From the [Table 6](#t0030){ref-type="table"}, compared with the blank group, in the model group, the thickness of thymic cortex and the volume of splenic nodules were significantly decreased (P \< 0.01); the thymic lobule cortex, the medulla clear boundaries, the cortical atrophy thinning, lymphocytes decreased significantly ([Fig. 2](#f0010){ref-type="fig"}B); the red pulp of spleen white pulp clear boundaries, splenic nodule was obviously reduced, lymphocyte sparse decreased obviously ([Fig. 3](#f0015){ref-type="fig"}B); indicating that after the perimenopausal model the mice of thymus, spleen volume atrophy ([@b0105]). Compared with the model group, the GNA capsule group, SIS capsule group, high dose group of TFR could significantly thickened the volume of splenic nodules and the thickness of thymic cortex (P \< 0.01), in this three groups, the thymic lobule cortex, medulla, clear boundary, the cortical thickening, denser lymphocyte ([Fig. 2](#f0010){ref-type="fig"}C, D, E); the spleen red and white pulp, clear boundary, splenic corpuscle increased significantly, lymphocyte dense ([Fig. 3](#f0015){ref-type="fig"}C, D, E); the mid dose group of TFR could thicken the thickness of thymic cortex (P \< 0.05). The cortical, medullary thymic lobule, clear boundary, cortical atrophy thinning dense, lymphocyte ([Fig. 2](#f0010){ref-type="fig"}F).Fig. 2Effect of thymus path morphology on the perimenopausal period in mice (HE × 200).Fig. 3Effect of spleen path morphology on the perimenopausal period in mice (HE × 200).Table 6Effects of TFR on the thymus, spleen path morphology in the mice perimenopausal model ($\overline{\text{x}}$ ± s, n = 12).GroupDose (mg/kg)Thymic cortex thickness (μm)Splenic nodule (μm)Blank group--337.94 ± 26.16[\*\*](#tblfn11){ref-type="table-fn"}427.88 ± 58.96[\*\*](#tblfn11){ref-type="table-fn"}Model group--215.51 ± 28.11261.52 ± 33.22GNA capsule group675364.53 ± 36.82[\*\*](#tblfn11){ref-type="table-fn"}381.28 ± 59.62[\*\*](#tblfn11){ref-type="table-fn"}SIS capsule group250321.42 ± 66.84[\*\*](#tblfn11){ref-type="table-fn"}340.71 ± 52.41[\*\*](#tblfn11){ref-type="table-fn"}TFR high-dose group200285.96 ± 42.13[\*\*](#tblfn11){ref-type="table-fn"}324.13 ± 35.51[\*\*](#tblfn11){ref-type="table-fn"}TFR mid-dose group100271.46 ± 37.77[\*](#tblfn10){ref-type="table-fn"}285.24 ± 25.81TFR low-dose group50279.91 ± 58.15257.07 ± 27.90[^17][^18][^19]

4. Discussion {#s0075}
=============

Ovaries castration produce menopausal model in mice, model group mice appeared the number of activities and standing significantly reduced; the curiosity of the fresh environment is reduced; the latency of entering the darkroom is significantly shorter, the number of electric shocks increased significantly, the memory of the mice decline; the levels of E2 and T are significantly decreased, and the levels of LH and FSH are significantly increased, sex hormone levels in mice serum disorder; uterine lesions, thymus, spleen volume atrophy; indicating that the perimenopausal mice model is successfully replicated. Given the high, mid and low dose TFR after a period, the phenomenon has been improved and relieved, the results showed that TFR had a good therapeutic effect on the perimenopausal model of mice.

Chinese medicine treatment of perimenopausal syndrome with kidney deficiency pathogenesis theory ([@b0065], [@b0100]), women into the perimenopausal period, kidney qi deficiency, red any two losses, lack of refined gas, menstrual disorders, as well as menopause, and accompanied by a series of symptoms, such as fanre, insomnia, more dreams. Kidney deficiency is the root cause of perimenopausal syndrome ([@b0110], [@b0030]). Recent studies have shown that the drug for kidney yang have estrogen-like effects, on perimenopausal syndrome have a better therapeutic effect ([@b0090]), and no side effects and contraindications. Western medicine treatment with hormone replacement method, has certain limitations. Raspberry is Rosaceae Rubus plants, medicine and food, and now has been widely used in medicine, food, health products, cosmetics and other industries ([@b0040], [@b0095]). Rubus plants contain rich flavonoids ([@b0055], [@b0050]), with anti-tumor, thrombosis, hypolipidemic, hypoglycemic, promote blood circulation, eliminate free radicals ([@b0005], [@b0085]), anti-aging effected ([@b0010]). Chinese medicine raspberry tonifying kidney, solid fine, shrink urine, commonly used in the treatment of kidney deficiency enuresis, urinary frequency, impotence premature ejaculation, spermatorrhea and so on ([@b0035]). Modern pharmacological studies have shown that raspberry has the effect of eliminating fatigue, improving immunity, improving learning and memory, and regulating gonadal axis, etc. ([@b0015]).

In this study, mice were removed by ovariectomy, to study the effect of TFR on perimenopausal models in mice, the results showed that TFR had better effect on the autonomic activity, memory and hormone level of perimenopausal mice. The ovariectomized animal model is relatively mature and has been widely used, however, the simulation of human perimenopausal syndrome is still inadequate, 90% of menopausal women ovarian is complete, the direct removal of the ovaries so that the body\'s estrogen levels suddenly decline, and also affected other hormone levels, such as luteinizing hormone, androgen and follicle-stimulating hormone ([@b0075], [@b0025], [@b0045]). Should further improve the method of model replication, simulation more in line with human perimenopausal animal model. Perimenopausal syndrome caused by metabolic disorders in the body, the symptoms are diverse, in addition to the above test indicators, but also the establishment of other corresponding indicators, more scientific and more comprehensive reflection of TFR on perimenopausal models of mice. TFR play a role in the treatment mechanism is still not clear, the need for further research. Comprehensive and thorough study of TFR on perimenopausal treatment, to develop a safe, reliable, significant treatment of perimenopausal drugs.
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